Measuring dopamine transporter occupancy by cocaine in vivo: Radiotracer considerations
- 1 February 1998
- Vol. 28 (2) , 111-116
- https://doi.org/10.1002/(sici)1098-2396(199802)28:2<111::aid-syn1>3.0.co;2-e
Abstract
Several recent neuroimaging studies in humans and in monkeys using different radiotracers have reported widely differing values of dopamine transporter (DAT) occupancy by doses of cocaine which are perceived as reinforcing by humans. Here we tested the hypothesis that the measurement of DAT occupancies by drugs with fast pharmacokinetics such as cocaine requires a radioligand with similar kinetics in order to effectively compete with the drug. We measured DAT occupancy by four different doses of cocaine (1.0, 0.5, 0.25, and 0.1 mg/kg) using [11C]d-threo-methylphenidate (a radiotracer which binds rapidly to the DAT in vivo) and compared them to estimates reported previously using [11C]cocaine in the same two baboons and with the same four doses of cocaine [Volkow et al. (1996b) Synapse 24:399-402). Cocaine reduced [11C]d-threo-methylphenidate binding in striatum in a dose-dependent manner, and values were significantly correlated with those obtained previously with [11C]cocaine (r = 0.9, F = 37, P < 0.001). The ED50s (50% occupancy of DAT by cocaine) were 0.27 and 0.17 mg/kg for [11C]d-threo-methylphenidate and [11C]cocaine, respectively. This is significantly lower than values obtained with labeled beta-CIT and other similar radiotracers with a slow uptake and clearance (ED50s: 3-7 mg/kg). We conclude that in vivo measurements of DAT occupancy by rapidly clearing drugs like cocaine requires the use of radiotracers having similar kinetics to the drug itself.Keywords
This publication has 20 references indexed in Scilit:
- Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaineBiochemical Pharmacology, 1997
- Displacement of RTI-55 from the dopamine transporter by cocaineEuropean Journal of Pharmacology, 1996
- Plasma input function determination for PET using a commercial laboratory robotNuclear Medicine and Biology, 1995
- Synthesis of the racemate and individual enantiomers of [11C]methylphenidate for studying presynaptic dopaminergic neuron with positron emission tomographyJournal of Labelled Compounds and Radiopharmaceuticals, 1994
- Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brainSynapse, 1994
- SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primatesSynapse, 1993
- GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomographyJournal of Neuroscience, 1992
- Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1991
- Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1990
- Mapping cocaine binding sites in human and baboon brain in vivoSynapse, 1989